Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Use of Pancreatic Enzymes in Short Bowel Syndrome
Brief Summary: Patients with short bowel syndrome have a high mortality rate that is mainly attributed to complications from central lines and long-term intravenous (IV) nutrition. There are few medical therapies to date that improve gut absorption in patients with short bowel syndrome. The primary objective of this study is to evaluate if absorption from the GI tract improves in subjects with short bowel syndrome following therapy with pancreatic enzymes.